| Year |
Citation |
Score |
| 2020 |
Mohamed S, Johnson GR, Sevilimedu V, Rao SD, Hicks PB, Chen P, Lauro K, Jurjus G, Pilkinton P, Davis L, Wilcox JA, Iranmanesh A, Sapra M, Aslam M, Michalets J, et al. Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial. The Journal of Clinical Psychiatry. 81. PMID 32603560 DOI: 10.4088/Jcp.19M13038 |
0.385 |
|
| 2019 |
Zisook S, Johnson GR, Tal I, Hicks P, Chen P, Davis L, Thase M, Zhao Y, Vertrees J, Mohamed S. General Predictors and Moderators of Depression Remission: A VAST-D Report. The American Journal of Psychiatry. appiajp201818091079. PMID 30947531 DOI: 10.1176/Appi.Ajp.2018.18091079 |
0.364 |
|
| 2018 |
Yoon J, Zisook S, Park A, Johnson GR, Scrymgeour A, Mohamed S. Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial. The Journal of Clinical Psychiatry. 80. PMID 30695291 DOI: 10.4088/Jcp.18M12294 |
0.322 |
|
| 2018 |
Rhee TG, Mohamed S, Rosenheck RA. Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015. The Journal of Clinical Psychiatry. 79. PMID 29469245 DOI: 10.4088/Jcp.17M11970 |
0.407 |
|
| 2017 |
Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, et al. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. Jama. 318: 132-145. PMID 28697253 DOI: 10.1001/Jama.2017.8036 |
0.373 |
|
| 2017 |
Mohamed S. Evaluating the Quality of Rural Intensive Case Management Services using Administrative Data: an Exploratory Study Psychiatric Quarterly. 88: 897-907. PMID 28293778 DOI: 10.1007/S11126-017-9505-Z |
0.357 |
|
| 2017 |
Zhou Y, Rosenheck R, Mohamed S, Ning Y, He H. Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge. Psychiatry Research. 250: 129-135. PMID 28160655 DOI: 10.1016/J.Psychres.2017.01.036 |
0.363 |
|
| 2016 |
Harpaz-Rotem I, Rosenheck R, Mohamed S, Pietrzak R, Hoff R. Initiation of pharmacotherapy for post-traumatic stress disorder among veterans from Iraq and Afghanistan: a dimensional, symptom cluster approach. Bjpsych Open. 2: 286-293. PMID 27703791 DOI: 10.1192/Bjpo.Bp.115.002451 |
0.334 |
|
| 2016 |
Zhou Y, Rosenheck R, Mohamed S, Ou Y, Ning Y, He H. Comparison of burden among family members of patients diagnosed with schizophrenia and bipolar disorder in a large acute psychiatric hospital in China. Bmc Psychiatry. 16: 283. PMID 27515535 DOI: 10.1186/S12888-016-0962-Y |
0.364 |
|
| 2016 |
Zisook S, Tal I, Weingart K, Hicks P, Davis LL, Chen P, Yoon J, Johnson GR, Vertrees JE, Rao S, Pilkinton PD, Wilcox JA, Sapra M, Iranmanesh A, Huang GD, ... Mohamed S, et al. Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require "next-step" treatments: A VAST-D report. Journal of Affective Disorders. 206: 232-240. PMID 27479536 DOI: 10.1016/J.Jad.2016.07.023 |
0.39 |
|
| 2016 |
Mohamed S. Comparison of intensive case management for psychotic and nonpsychotic patients. Psychological Services. 13: 10-9. PMID 26168139 DOI: 10.1037/Ser0000041 |
0.415 |
|
| 2015 |
Mohamed S, Johnson GR, Vertrees JE, Guarino PD, Weingart K, Young IT, Yoon J, Gleason TC, Kirkwood KA, Kilbourne AM, Gerrity M, Marder S, Biswas K, Hicks P, Davis LL, et al. The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations. Psychiatry Research. PSYD1500402. PMID 26279130 DOI: 10.1016/J.Psychres.2015.08.005 |
0.361 |
|
| 2015 |
Mohamed S, Rosenheck RA, Lin H, Swartz M, McEvoy J, Stroup S. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. The Journal of Nervous and Mental Disease. 203: 486-92. PMID 26075840 DOI: 10.1097/Nmd.0000000000000317 |
0.339 |
|
| 2015 |
Zhou Y, Rosenheck R, Mohamed S, Zhang J, Chang Q, Ou Y, Sun B, Ning Y, He H. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning. Schizophrenia Research. 161: 376-81. PMID 25533592 DOI: 10.1016/J.Schres.2014.12.009 |
0.436 |
|
| 2015 |
Mohamed S. Can small intensive case management teams be as effective as large teams? Community Mental Health Journal. 51: 161-4. PMID 24821332 DOI: 10.1007/S10597-014-9730-Y |
0.322 |
|
| 2014 |
Zhang J, Rosenheck R, Mohamed S, Zhou Y, Chang Q, Ning Y, He H. Association of symptom severity, insight and increased pharmacologic side effects in acutely hospitalized patients with schizophrenia. Comprehensive Psychiatry. 55: 1914-9. PMID 25217308 DOI: 10.1016/J.Comppsych.2014.07.018 |
0.427 |
|
| 2014 |
Zhou Y, Rosenheck RA, Mohamed S, Fan N, Ning Y, He H. Retrospective assessment of factors associated with readmission in a large psychiatric hospital in Guangzhou, China. Shanghai Archives of Psychiatry. 26: 138-48. PMID 25114488 DOI: 10.3969/J.Issn.1002-0829.2014.03.005 |
0.338 |
|
| 2014 |
Mohamed S, Rosenheck R, He H, Yuping N. Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China. Social Psychiatry and Psychiatric Epidemiology. 49: 1063-70. PMID 24549835 DOI: 10.1007/S00127-014-0824-1 |
0.419 |
|
| 2013 |
Vahia IV, Lanouette NM, Golshan S, Fellows I, Mohamed S, Kasckow JW, Zisook S. Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms. Indian Journal of Psychiatry. 55: 144-8. PMID 23825848 DOI: 10.4103/0019-5545.111452 |
0.454 |
|
| 2013 |
Mohamed S. Adaptation of intensive mental health intensive case management to rural communities in the Veterans Health Administration. The Psychiatric Quarterly. 84: 103-14. PMID 22729625 DOI: 10.1007/S11126-012-9231-5 |
0.354 |
|
| 2012 |
Dawes SE, Palmer BW, Meeks T, Golshan S, Kasckow J, Mohamed S, Zisook S. Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression? Neuropsychobiology. 65: 168-72. PMID 22456094 DOI: 10.1159/000331141 |
0.466 |
|
| 2012 |
Mohamed S, Rosenheck R, Lyketsos CG, Kaczynski R, Sultzer DL, Schneider LS. Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease. The Journal of Clinical Psychiatry. 73: 121-8. PMID 21939611 DOI: 10.4088/Jcp.10M06574 |
0.343 |
|
| 2011 |
Addington DE, Mohamed S, Rosenheck RA, Davis SM, Stroup TS, McEvoy JP, Swartz MS, Lieberman JA. Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia. The Journal of Clinical Psychiatry. 72: 75-80. PMID 20868641 DOI: 10.4088/Jcp.09M05258Gre |
0.467 |
|
| 2011 |
Osatuke K, Reid M, Stiles WB, Kasckow JW, Zisook S, Mohamed S. Narrative evolution and assimilation of problematic experiences in a case of pharmacotherapy for schizophrenia. Psychotherapy Research : Journal of the Society For Psychotherapy Research. 21: 41-53. PMID 20845225 DOI: 10.1080/10503307.2010.508760 |
0.406 |
|
| 2010 |
Zisook S, Kasckow JW, Lanouette NM, Golshan S, Fellows I, Vahia I, Mohamed S, Rao S. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial. The Journal of Clinical Psychiatry. 71: 915-22. PMID 20361918 DOI: 10.4088/Jcp.09M05699Gre |
0.452 |
|
| 2009 |
Mohamed S, Rosenheck R, Harpaz-Rotem I, Leslie D, Sernyak MJ. Duration of pharmacotherapy with long-acting injectable risperidone in the treatment of schizophrenia. The Psychiatric Quarterly. 80: 241-9. PMID 19768543 DOI: 10.1007/S11126-009-9111-9 |
0.402 |
|
| 2009 |
Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system. Psychiatric Services (Washington, D.C.). 60: 1175-81. PMID 19723731 DOI: 10.1176/Ps.2009.60.9.1175 |
0.388 |
|
| 2009 |
Mohamed S, Neale MS, Rosenheck R. Veterans Affairs Intensive Case Management for older veterans. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 671-81. PMID 19625784 DOI: 10.1097/Jgp.0B013E3181A88340 |
0.313 |
|
| 2009 |
Mohamed S, Leslie DL, Rosenheck RA. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs. The Journal of Clinical Psychiatry. 70: 906-12. PMID 19422760 DOI: 10.4088/Jcp.08M04450 |
0.399 |
|
| 2009 |
Zisook S, Kasckow JW, Golshan S, Fellows I, Solorzano E, Lehman D, Mohamed S, Jeste DV. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. The Journal of Clinical Psychiatry. 70: 562-71. PMID 19192468 DOI: 10.4088/Jcp.08M04261 |
0.497 |
|
| 2009 |
Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophrenia Bulletin. 35: 336-46. PMID 18586692 DOI: 10.1093/Schbul/Sbn067 |
0.319 |
|
| 2009 |
Owens GP, Dashevsky B, Chard KM, Mohamed S, Haji U, Heppner PS, Baker DG. The relationship between childhood trauma, combat exposure, and posttraumatic stress disorder in male veterans Military Psychology. 21: 114-125. DOI: 10.1080/08995600802574530 |
0.307 |
|
| 2008 |
Harpaz-Rotem I, Rosenheck RA, Mohamed S, Desai RA. Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans. Psychiatric Services (Washington, D.C.). 59: 1184-90. PMID 18832505 DOI: 10.1176/Appi.Ps.59.10.1184 |
0.321 |
|
| 2008 |
Mohamed S, Rosenheck R. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 804-12. PMID 18827226 DOI: 10.1097/Jgp.0B013E318173F617 |
0.306 |
|
| 2008 |
Kasckow J, Patterson T, Fellows I, Golshan S, Solorzano E, Mohamed S, Zisook S. Functioning in middle aged and older patients with schizophrenia and depressive symptoms: relationship to psychopathology. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 660-3. PMID 18669944 DOI: 10.1097/Jgp.0B013E31816Ff746 |
0.435 |
|
| 2008 |
Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. The Journal of Clinical Psychiatry. 69: 959-65. PMID 18588361 DOI: 10.4088/Jcp.V69N0611 |
0.337 |
|
| 2008 |
Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. Relationship of cognition and psychopathology to functional impairment in schizophrenia. The American Journal of Psychiatry. 165: 978-87. PMID 18450928 DOI: 10.1176/Appi.Ajp.2008.07111713 |
0.376 |
|
| 2008 |
Roseman AS, Kasckow J, Fellows I, Osatuke K, Patterson TL, Mohamed S, Zisook S. Insight, quality of life, and functional capacity in middle-aged and older adults with schizophrenia. International Journal of Geriatric Psychiatry. 23: 760-5. PMID 18205246 DOI: 10.1002/Gps.1978 |
0.35 |
|
| 2008 |
Osatuke K, Ciesla J, Kasckow JW, Zisook S, Mohamed S. Insight in schizophrenia: a review of etiological models and supporting research. Comprehensive Psychiatry. 49: 70-7. PMID 18063044 DOI: 10.1016/J.Comppsych.2007.08.001 |
0.405 |
|
| 2007 |
Zisook S, Montross L, Kasckow J, Mohamed S, Palmer BW, Patterson TL, Golshan S, Fellows I, Lehman D, Solorzano E. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 15: 1005-14. PMID 18056819 DOI: 10.1097/Jgp.0B013E3180A725Ec |
0.451 |
|
| 2006 |
Mohamed S, Osatuke K, Aslam M, Kasckow J. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial. The American Journal of Geriatric Pharmacotherapy. 4: 201-9. PMID 17062320 DOI: 10.1016/J.Amjopharm.2006.08.001 |
0.37 |
|
| 2006 |
Mohamed S, Bondi MW, Kasckow JW, Golshan S, Jeste DV. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia. International Journal of Geriatric Psychiatry. 21: 711-8. PMID 16862606 DOI: 10.1002/Gps.1528 |
0.358 |
|
| 2005 |
Owens GP, Baker DG, Kasckow J, Ciesla JA, Mohamed S. Review of assessment and treatment of PTSD among elderly American armed forces veterans. International Journal of Geriatric Psychiatry. 20: 1118-30. PMID 16315160 DOI: 10.1002/Gps.1408 |
0.318 |
|
| 2005 |
Harvey PD, Palmer BW, Heaton RK, Mohamed S, Kennedy J, Brickman A. Stability of cognitive performance in older patients with schizophrenia: an 8-week test-retest study. The American Journal of Psychiatry. 162: 110-7. PMID 15625208 DOI: 10.1176/Appi.Ajp.162.1.110 |
0.307 |
|
| 2004 |
Depp CA, Jin H, Mohamed S, Kaskow J, Moore DJ, Jeste DV. Bipolar disorder in middle-aged and elderly adults: is age of onset important? The Journal of Nervous and Mental Disease. 192: 796-9. PMID 15505527 DOI: 10.1097/01.Nmd.0000145055.45944.D6 |
0.364 |
|
| 2004 |
Kasckow JW, Mulchahey JJ, Mohamed S. The Use of Novel Antipsychotics in the Older Patient With Neurodegenerative Disorders in the Long-Term Care Setting Journal of the American Medical Directors Association. 5: 242-248. DOI: 10.1016/S1525-8610(04)70130-9 |
0.367 |
|
| 2002 |
Kasckow JW, Mohamed S, Thallasinos A, Carroll B, Zisook S, Jeste DV. Citalopram augmentation of antipsychotic treatment in older schizophrenia patients. International Journal of Geriatric Psychiatry. 16: 1163-7. PMID 11748776 DOI: 10.1002/Gps.508 |
0.455 |
|
| 2000 |
Kim JJ, Mohamed S, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. The American Journal of Psychiatry. 157: 542-8. PMID 10739412 DOI: 10.1176/Appi.Ajp.157.4.542 |
0.371 |
|
| 1999 |
Mohamed S, Fleming S, Penn DL, Spaulding W. Insight in schizophrenia: its relationship to measures of executive functions. Journal of Nervous and Mental Disease. 187: 525-531. PMID 10496507 DOI: 10.1097/00005053-199909000-00001 |
0.418 |
|
| 1999 |
Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: A study of first- episode patients Archives of General Psychiatry. 56: 749-754. PMID 10435610 DOI: 10.1001/Archpsyc.56.8.749 |
0.422 |
|
| 1999 |
Hawkins KA, Mohamed S, Woods SW. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia? Psychological Medicine. 29: 1-8. PMID 10077288 DOI: 10.1017/S0033291798006990 |
0.37 |
|
| Show low-probability matches. |